Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences, College of Stomatology, Chongqing Medical University, Chongqing, China.
Front Public Health. 2022 Dec 19;10:910145. doi: 10.3389/fpubh.2022.910145. eCollection 2022.
Excessive fear of progression can affect the mental health, social function, and wellbeing of patients with chronic diseases. This study investigated the fear of progression (FoP) and the socio-demographic and clinical predictors among patients with type 2 diabetes mellitus (T2DM).
The present study is a multi-center cross-sectional study. Inpatients with T2DM were recruited by a multi-stage convenience sampling method from the department of endocrinology in 5 tertiary hospitals in Southwest China. 459 T2DM patients were consecutively enrolled. Socio-demographic, clinical data, and answers to the fear of progression questionnaire (FoP-Q) were collected.
385 patients with complete data were eligible. The average score of FoP-Q-SF was 26.84 and 23.1% of patients reached the dysfunctional fear of progression criterion. The greatest fears were worrying about "disease progression," "the adverse reactions of medication," and "relying on strangers for activities of daily living." Health education ( < 0.001), age ( = 0.002), hypoglycemia history ( = 0.006), employment status ( = 0.025) and duration since being diagnosed with type 2 diabetes mellitus ( = 0.032) were the related factors of fear of progression.
Early assessment of the fear of progression was imperative to identify dysfunctional fear of progression in patients with type 2 diabetes mellitus. Meanwhile, the meaning of these predictors for strengthening healthcare professions education and patients self-management might help healthcare givers timely perform related interventions and help patients reduce their fear of progression thus actively cooperate with T2DM treatments.
过度担心疾病进展可能会影响慢性病患者的心理健康、社会功能和生活幸福感。本研究旨在探讨 2 型糖尿病（T2DM）患者的疾病进展恐惧（FoP）及其社会人口学和临床预测因素。
本研究为多中心横断面研究。采用多阶段便利抽样方法，从中国西南地区 5 家三级医院的内分泌科招募 T2DM 住院患者。连续纳入 459 例 T2DM 患者。收集社会人口学、临床资料和疾病进展恐惧问卷（FoP-Q）的答案。
385 例患者资料完整，FoP-Q-SF 的平均得分为 26.84，23.1%的患者达到了功能失调性疾病进展恐惧的标准。患者最担心的是“疾病进展”、“药物的不良反应”和“日常生活依赖他人”。健康教育（<0.001）、年龄（=0.002）、低血糖史（=0.006）、就业状况（=0.025）和确诊为 2 型糖尿病的时间（=0.032）是疾病进展恐惧的相关因素。
早期评估疾病进展恐惧对于识别 2 型糖尿病患者的功能失调性疾病进展恐惧至关重要。同时，这些预测因素对于加强医疗保健专业人员的教育和患者的自我管理具有重要意义，可以帮助医疗保健提供者及时进行相关干预，帮助患者减少对疾病进展的恐惧，从而积极配合 2 型糖尿病的治疗。
